What is he best known for?
The fields of study he is best known for:
James E. Krause mainly focuses on Molecular biology, Substance P, Internal medicine, Endocrinology and Biochemistry.
His Molecular biology research includes themes of Receptor, Neuropeptide K, Gene expression and Olfactory tubercle.
His study in the field of Preprotachykinin and Neurokinin A also crosses realms of Mucus.
As part of his studies on Internal medicine, James E. Krause frequently links adjacent subjects like Cell biology.
The Endocrinology study combines topics in areas such as Capsazepine, Calcium, Immunology, Biopsy and Receptor antagonist.
His Biochemistry research incorporates themes from Calcium-activated potassium channel and BK channel.
His most cited work include:
- Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. (706 citations)
- Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. (594 citations)
- Differential expression of insulin-like growth factor genes in rat central nervous system. (426 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Receptor, Substance P, Endocrinology, Internal medicine and Molecular biology.
His Receptor course of study focuses on Pharmacology and Capsaicin.
His Endocrinology study combines topics from a wide range of disciplines, such as Neuropeptide, Neurokinin B and Gene expression.
His Internal medicine study typically links adjacent topics like Cell biology.
Molecular biology is closely attributed to Substance-P Receptor in his research.
His study in Neurokinin A is interdisciplinary in nature, drawing from both Neuropeptide K and Signal transduction.
He most often published in these fields:
- Receptor (38.93%)
- Substance P (38.17%)
- Endocrinology (38.17%)
What were the highlights of his more recent work (between 2003-2011)?
- Receptor (38.93%)
- Antagonist (8.40%)
- Pharmacology (9.16%)
In recent papers he was focusing on the following fields of study:
His main research concerns Receptor, Antagonist, Pharmacology, TRPV1 and Capsaicin.
His Receptor study results in a more complete grasp of Biochemistry.
Many of his research projects under Biochemistry are closely connected to Gerbil with Gerbil, tying the diverse disciplines of science together.
The study incorporates disciplines such as Amino acid, Neuron, Small molecule and Arthritis in addition to Antagonist.
His Pharmacology research is multidisciplinary, incorporating perspectives in Inflammation and Biological activity.
His biological study spans a wide range of topics, including Yohimbine, Adrenergic receptor, Ion channel, Neuroscience and Dorsal root ganglion.
Between 2003 and 2011, his most popular works were:
- TRP channels and pain. (81 citations)
- Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation (64 citations)
- Transient receptor potential ion channels as targets for the discovery of pain therapeutics. (55 citations)
In his most recent research, the most cited papers focused on:
James E. Krause mainly investigates Receptor, Pharmacology, TRPV1, Transient receptor potential channel and Capsaicin.
He regularly links together related areas like Biological activity in his Receptor studies.
His Pharmacology research incorporates elements of In vitro, Arthritis, Inflammation, Antagonist and Benzamide.
His TRPV1 study incorporates themes from TRPV4, Ion channel, Nociceptor and Voltage-dependent calcium channel.
He combines subjects such as Sensory neuron, Neuroscience and Neurotransmitter with his study of Transient receptor potential channel.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
